AAAAAA

   
Results: 1-23 |
Results: 23

Authors: Bittmann, I Dose, T Baretton, GB Muller, C Schwaiblmair, M Kur, F Lohrs, U
Citation: I. Bittmann et al., Cellular chimerism of the lung after transplantation - An interphase cytogenetic study, AM J CLIN P, 115(4), 2001, pp. 525-533

Authors: Peiro, G Diebold, J Mayr, D Baretton, GB Kimmig, R Schmidt, M Lohrs, U
Citation: G. Peiro et al., Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma, MOD PATHOL, 14(8), 2001, pp. 777-783

Authors: Aust, DE Terdiman, TP Willenbucher, RF Chew, K Ferrell, L Florendo, C Molinaro-Clark, A Baretton, GB Lohrs, U Waldman, FM
Citation: De. Aust et al., Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers, MOD PATHOL, 14(1), 2001, pp. 29-39

Authors: Lebeau, A Deimling, D Kaltz, C Sendelhofert, A Iff, A Luthardt, B Untch, M Lohrs, U
Citation: A. Lebeau et al., HER-2/neu analysis in archival tissue samples of human breast cancer: Comparison of immunohistochemistry and fluorescence in situ hybridization, J CL ONCOL, 19(2), 2001, pp. 354-363

Authors: Peiro, G Diebold, J Baretton, GB Kimmig, R Lohrs, U
Citation: G. Peiro et al., Cellular apoptosis susceptibility gene expression in endometrial carcinoma: Correlation with Bcl-2, Bax, and caspase-3 expression and outcome, INT J GYN P, 20(4), 2001, pp. 359-367

Authors: Zietz, C Rumpler, U Sturzl, M Lohrs, U
Citation: C. Zietz et al., Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma - Indications of apoptotic tumor counterattack, AM J PATH, 159(3), 2001, pp. 963-970

Authors: Huss, R Haas, C Herrmann, M Kalden, JR Lohrs, U
Citation: R. Huss et al., Impairment of genomic DNA binding to a putative dysfunctional receptor on erythrocytes independent of complement and antibodies in systemic lupus erythematosus, VIRCHOWS AR, 437(4), 2000, pp. 380-387

Authors: Stoll, C Baretton, G Ahrens, C Lohrs, U
Citation: C. Stoll et al., Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma, VIRCHOWS AR, 436(2), 2000, pp. 102-108

Authors: Schaller, UC Mueller, AJ Bosserhoff, AK Haraida, S Lohrs, U Buettner, R Kampik, A
Citation: Uc. Schaller et al., Melanoma inhibitory activity (MIA). Evaluation of a novel tumorassociated antigen as a serum marker for uveal Melanoma, OPHTHALMOLO, 97(6), 2000, pp. 429-432

Authors: Ihrler, S Baretton, GB Menauer, F Blasenbreu-Vogt, S Lohrs, U
Citation: S. Ihrler et al., Sjogren's syndrome and MALT lymphomas of salivary glands: A DNA-cytometricand interphase-cytogenetic study, MOD PATHOL, 13(1), 2000, pp. 4-12

Authors: Ihrler, S Zietz, C Sendelhofert, A Menauer, F Blasenbreu-Vogt, S Lohrs, U
Citation: S. Ihrler et al., Differential diagnosis of lymphoepithelial lesions of salivary glands. With particular reference to characteristic duct lesions, PATHOLOGE, 21(6), 2000, pp. 424-432

Authors: Kaltz-Wittmer, C Klenk, U Glaessgen, A Aust, DE Diebold, J Lohrs, U Baretton, GB
Citation: C. Kaltz-wittmer et al., FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy, LAB INV, 80(9), 2000, pp. 1455-1464

Authors: Diebold, J Mosinger, K Peiro, G Pannekamp, U Kaltz, C Baretton, GB Meier, W Lohrs, U
Citation: J. Diebold et al., 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization, J PATHOLOGY, 190(5), 2000, pp. 564-571

Authors: Stoll, C Baretton, G Soost, F Terpe, HJ Domide, P Lohrs, U
Citation: C. Stoll et al., Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas, ORAL ONCOL, 35(5), 1999, pp. 484-489

Authors: Ihrler, S Zietz, C Sendelhofert, A Riederer, A Lohrs, U
Citation: S. Ihrler et al., Lymphoepithelial duct lesions in Sjogren-type sialadenitis, VIRCHOWS AR, 434(4), 1999, pp. 315-323

Authors: Haas, CJ Diebold, J Hirschmann, A Rohrbach, H Lohrs, U
Citation: Cj. Haas et al., In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential, VIRCHOWS AR, 434(2), 1999, pp. 117-120

Authors: Weissbach, L Bussar-Maatz, R Lohrs, U Schubert, GE Mann, K Hartmann, M Dieckmann, KP Fassbinder, J
Citation: L. Weissbach et al., Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study, EUR UROL, 36(6), 1999, pp. 601-608

Authors: Haas, CJ Diebold, J Hirschmann, A Rohrbach, H Schmid, S Lohrs, U
Citation: Cj. Haas et al., Microsatellite analysis in serous tumors of the ovary, INT J GYN P, 18(2), 1999, pp. 158-162

Authors: Rohrbach, H Haas, CJ Baretton, GB Hirschmann, A Diebold, J Behrendt, RP Lohrs, U
Citation: H. Rohrbach et al., Microsatellite instability and loss of heterozygosity in prostatic carcinomas: Comparison of primary tumors, and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastases, PROSTATE, 40(1), 1999, pp. 20-27

Authors: Lebeau, A Nerlich, AG Sauer, U Lichtinghagen, R Lohrs, U
Citation: A. Lebeau et al., Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas, ANTICANC R, 19(5B), 1999, pp. 4257-4264

Authors: Zietz, C Bogner, JR Goebel, FD Lohrs, U
Citation: C. Zietz et al., An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS, N ENG J MED, 340(24), 1999, pp. 1923-1924

Authors: Wolff, H Kunte, C Messer, G Rappersberger, K Held, E Lohrs, U Plewig, G Meurer, M
Citation: H. Wolff et al., Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour, BR J DERM, 140(2), 1999, pp. 313-316

Authors: Baretton, GB Klenk, U Diebold, J Schmeller, N Lohrs, U
Citation: Gb. Baretton et al., Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression, BR J CANC, 80(3-4), 1999, pp. 546-555
Risultati: 1-23 |